Stock & Company Details
Cognition Therapeutics Inc $CGTX
Price:
N/A
N/A
95M
$71M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.87
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CGTX technical indicators
Latest Cognition Therapeutics Inc (CGTX) indicator readings as of 2026-10-29.
CGTX's 14-day RSI is 37.3, in neutral territory. At $0.74 it is trading 30.9% below its 200-day moving average of $1.07, and below its 50-day average of $0.92. Price sits in the middle of its Bollinger Bands ($0.62 to $0.98). ADX reads 28.0, indicating a trending market.
Overview
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Finance Bot
Ask your questions
Start by typing a question below.
